532 related articles for article (PubMed ID: 17138902)
1. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist.
Poole AJ; Li Y; Kim Y; Lin SC; Lee WH; Lee EY
Science; 2006 Dec; 314(5804):1467-70. PubMed ID: 17138902
[TBL] [Abstract][Full Text] [Related]
2. Medicine. Squelching progesterone's signal may prevent breast cancer.
Marx J
Science; 2006 Dec; 314(5804):1370. PubMed ID: 17138873
[No Abstract] [Full Text] [Related]
3. Promotion of BRCA1-associated triple-negative breast cancer by ovarian hormones.
Lee EY
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):68-73. PubMed ID: 18197009
[TBL] [Abstract][Full Text] [Related]
4. Isolation of a stromal cell line from an early passage of a mouse mammary tumor line: a model for stromal parenchymal interactions.
Lamb CA; Fabris V; Gorostiaga MA; Helguero LA; Efeyan A; Bottino MC; Simian M; Soldati R; Sanjuan N; Molinolo A; Lanari C
J Cell Physiol; 2005 Mar; 202(3):672-82. PubMed ID: 15389583
[TBL] [Abstract][Full Text] [Related]
5. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
[TBL] [Abstract][Full Text] [Related]
6. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.
Xu X; Wagner KU; Larson D; Weaver Z; Li C; Ried T; Hennighausen L; Wynshaw-Boris A; Deng CX
Nat Genet; 1999 May; 22(1):37-43. PubMed ID: 10319859
[TBL] [Abstract][Full Text] [Related]
7. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells.
Li M; Zhao D; Ma G; Zhang B; Fu X; Zhu Z; Fu L; Sun X; Dong JT
Biochem Biophys Res Commun; 2013 Jan; 430(1):358-63. PubMed ID: 23159610
[TBL] [Abstract][Full Text] [Related]
9. Dual roles for macrophages in ovarian cycle-associated development and remodelling of the mammary gland epithelium.
Chua AC; Hodson LJ; Moldenhauer LM; Robertson SA; Ingman WV
Development; 2010 Dec; 137(24):4229-38. PubMed ID: 21068060
[TBL] [Abstract][Full Text] [Related]
10. The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.
Ma Y; Katiyar P; Jones LP; Fan S; Zhang Y; Furth PA; Rosen EM
Mol Endocrinol; 2006 Jan; 20(1):14-34. PubMed ID: 16109739
[TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor A stability is mediated by glycogen synthase kinase-3β in the Brca1-deficient mammary gland.
Wang S; Li Y; Hsu PH; Lee SY; Kim Y; Lee EYP
J Biol Chem; 2013 Sep; 288(36):26265-26274. PubMed ID: 23880761
[TBL] [Abstract][Full Text] [Related]
12. Brca1 regulates in vitro differentiation of mammary epithelial cells.
Kubista M; Rosner M; Kubista E; Bernaschek G; Hengstschläger M
Oncogene; 2002 Jul; 21(31):4747-56. PubMed ID: 12101413
[TBL] [Abstract][Full Text] [Related]
13. Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice.
Brodie SG; Xu X; Qiao W; Li WM; Cao L; Deng CX
Oncogene; 2001 Nov; 20(51):7514-23. PubMed ID: 11709723
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.
Calvo V; Beato M
Cancer Res; 2011 May; 71(9):3422-31. PubMed ID: 21531767
[TBL] [Abstract][Full Text] [Related]
15. Progesterone induces BRCA1 mRNA decrease, cell cycle alterations and apoptosis in the MCF7 breast cancer cell line.
Ansquer Y; Legrand A; Bringuier AF; Vadrot N; Lardeux B; Mandelbrot L; Feldmann G
Anticancer Res; 2005; 25(1A):243-8. PubMed ID: 15816544
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitive effects of mifepristone on growth of breast cancer: experiment with animal model].
Tian XS; Zhou WH; Wu GJ; Sun JZ; Cong MH
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):559-63. PubMed ID: 18649774
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-triggered delays in mammary gland gene expression during the estrous cycle: evidence for a novel timing system.
Silberstein GB; Van Horn K; Hrabeta-Robinson E; Compton J
J Endocrinol; 2006 Aug; 190(2):225-39. PubMed ID: 16899557
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles of BRCA1 in transcriptional regulation and DNA repair.
Chen Y; Lee WH; Chew HK
J Cell Physiol; 1999 Dec; 181(3):385-92. PubMed ID: 10528224
[TBL] [Abstract][Full Text] [Related]
19. Generation and analysis of Brca1 conditional knockout mice.
Deng CX; Xu X
Methods Mol Biol; 2004; 280():185-200. PubMed ID: 15187254
[TBL] [Abstract][Full Text] [Related]
20. Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model.
Raafat AM; Hofseth LJ; Haslam SZ
Am J Obstet Gynecol; 2001 Feb; 184(3):340-9. PubMed ID: 11228484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
